Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Pharmacokinetic and anti-cancer properties of high dose ascorbate in solid tumours of ascorbate-dependent mice.

Campbell EJ, Vissers MC, Wohlrab C, Hicks KO, Strother RM, Bozonet SM, Robinson BA, Dachs GU.

Free Radic Biol Med. 2016 Oct;99:451-462. doi: 10.1016/j.freeradbiomed.2016.08.027. Epub 2016 Aug 24.

PMID:
27567539
2.
3.

Task Shifting and Skin Punch for the Histologic Diagnosis of Kaposi's Sarcoma in Sub-Saharan Africa: A Public Health Solution to a Public Health Problem.

Laker-Oketta MO, Wenger M, Semeere A, Castelnuovo B, Kambugu A, Lukande R, Asirwa FC, Busakhala N, Buziba N, Diero L, Wools-Kaloustian K, Strother RM, Bwana M, Muyindike W, Amerson E, Mbidde E, Maurer T, Martin J.

Oncology. 2015;89(1):60-5. doi: 10.1159/000375165. Epub 2015 Feb 27.

4.

A Phase I First-in-Human Study of Enoticumab (REGN421), a Fully Human Delta-like Ligand 4 (Dll4) Monoclonal Antibody in Patients with Advanced Solid Tumors.

Chiorean EG, LoRusso P, Strother RM, Diamond JR, Younger A, Messersmith WA, Adriaens L, Liu L, Kao RJ, DiCioccio AT, Kostic A, Leek R, Harris A, Jimeno A.

Clin Cancer Res. 2015 Jun 15;21(12):2695-703. doi: 10.1158/1078-0432.CCR-14-2797. Epub 2015 Feb 27.

5.

An open-label phase Ib dose-escalation study of TRC105 (anti-endoglin antibody) with bevacizumab in patients with advanced cancer.

Gordon MS, Robert F, Matei D, Mendelson DS, Goldman JW, Chiorean EG, Strother RM, Seon BK, Figg WD, Peer CJ, Alvarez D, Adams BJ, Theuer CP, Rosen LS.

Clin Cancer Res. 2014 Dec 1;20(23):5918-26. doi: 10.1158/1078-0432.CCR-14-1143. Epub 2014 Sep 26.

6.

Influence of health-insurance access and hospital retention policies on childhood cancer treatment in Kenya.

Mostert S, Njuguna F, van de Ven PM, Olbara G, Kemps LJ, Musimbi J, Strother RM, Aluoch LM, Skiles J, Buziba NG, Sitaresmi MN, Vreeman RC, Kaspers GJ.

Pediatr Blood Cancer. 2014 May;61(5):913-8. doi: 10.1002/pbc.24896. Epub 2013 Dec 17.

PMID:
24347434
7.

Modelling the sitagliptin effect on dipeptidyl peptidase-4 activity in adults with haematological malignancies after umbilical cord blood haematopoietic cell transplantation.

Vélez de Mendizábal N, Strother RM, Farag SS, Broxmeyer HE, Messina-Graham S, Chitnis SD, Bies RR.

Clin Pharmacokinet. 2014 Mar;53(3):247-59. doi: 10.1007/s40262-013-0109-y.

8.

Prevalence and correlates of pain and pain treatment in a western Kenya referral hospital.

Huang KT, Owino C, Gramelspacher GP, Monahan PO, Tabbey R, Hagembe M, Strother RM, Njuguna F, Vreeman RC.

J Palliat Med. 2013 Oct;16(10):1260-7. doi: 10.1089/jpm.2013.0080. Epub 2013 Sep 13.

9.

In vivo DPP-4 inhibition to enhance engraftment of single-unit cord blood transplants in adults with hematological malignancies.

Farag SS, Srivastava S, Messina-Graham S, Schwartz J, Robertson MJ, Abonour R, Cornetta K, Wood L, Secrest A, Strother RM, Jones DR, Broxmeyer HE.

Stem Cells Dev. 2013 Apr 1;22(7):1007-15. doi: 10.1089/scd.2012.0636. Epub 2013 Feb 15.

10.

Literature based drug interaction prediction with clinical assessment using electronic medical records: novel myopathy associated drug interactions.

Duke JD, Han X, Wang Z, Subhadarshini A, Karnik SD, Li X, Hall SD, Jin Y, Callaghan JT, Overhage MJ, Flockhart DA, Strother RM, Quinney SK, Li L.

PLoS Comput Biol. 2012;8(8):e1002614. doi: 10.1371/journal.pcbi.1002614. Epub 2012 Aug 9.

11.

Building cancer nursing skills in a resource-constrained government hospital.

Strother RM, Fitch M, Kamau P, Beattie K, Boudreau A, Busakhalla N, Loehrer PJ.

Support Care Cancer. 2012 Sep;20(9):2211-5. doi: 10.1007/s00520-012-1482-z. Epub 2012 May 8.

PMID:
22565597
12.

Assessment of the face validity of two pain scales in Kenya: a validation study using cognitive interviewing.

Huang KT, Owino C, Vreeman RC, Hagembe M, Njuguna F, Strother RM, Gramelspacher GP.

BMC Palliat Care. 2012 Jul 10;11:5. doi: 10.1186/1472-684X-11-5.

13.

The oncology pharmacy in cancer care delivery in a resource-constrained setting in western Kenya.

Strother RM, Rao KV, Gregory KM, Jakait B, Busakhala N, Schellhase E, Pastakia S, Krzyzanowska M, Loehrer PJ.

J Oncol Pharm Pract. 2012 Dec;18(4):406-16. doi: 10.1177/1078155211434852. Epub 2012 Jan 16.

PMID:
22249828
14.

AIDS-Related Non-Hodgkin's Lymphoma in Sub-Saharan Africa: Current Status and Realities of Therapeutic Approach.

Mwamba PM, Mwanda WO, Busakhala N, Strother RM, Loehrer PJ, Remick SC.

Lymphoma. 2012;2012. doi: 10.1155/2012/904367.

15.

Retrospective analysis of the efficacy of gemcitabine for previously treated AIDS-associated Kaposi's sarcoma in western Kenya.

Strother RM, Gregory KM, Pastakia SD, Were P, Tenge C, Busakhala N, Jakait B, Schellhase EM, Rosmarin AG, Loehrer PJ.

Oncology. 2010;78(1):5-11. doi: 10.1159/000292356. Epub 2010 Mar 6.

16.

Lessons learned from development of docetaxel.

Strother RM, Sweeney C.

Expert Opin Drug Metab Toxicol. 2008 Jul;4(7):1007-19. doi: 10.1517/17425255.4.7.1007 . Review.

PMID:
18624687
17.

A phase I and pharmacokinetic trial of erlotinib in combination with weekly docetaxel in patients with taxane-naive malignancies.

Chiorean EG, Porter JM, Foster AE, Al Omari AS, Yoder CA, Fife KL, Strother RM, Murry DJ, Yu M, Jones DR, Sweeney CJ.

Clin Cancer Res. 2008 Feb 15;14(4):1131-7. doi: 10.1158/1078-0432.CCR-07-0437.

18.

Characterization of oxidative stress in various tissues of diabetic and galactose-fed rats.

Strother RM, Thomas TG, Otsyula M, Sanders RA, Watkins JB 3rd.

Int J Exp Diabetes Res. 2001;2(3):211-6.

Supplemental Content

Loading ...
Support Center